Suzano S.A. stock (BRSUZBACNOR0): Record pulp volumes and new tissue JV with Kimberly-Clark in focus

Suzano S.A. reports record annual pulp sales volumes and announces a global tissue joint venture with Kimberly-Clark, drawing attention from US investors.

Suzano S.A. stock has moved into the spotlight after the Brazilian pulp and paper giant reported record annual pulp sales volumes and unveiled a major joint venture with Kimberly?Clark to create a global tissue company. The moves highlight Suzano’s scale in eucalyptus pulp and its push into higher?value tissue products, which could influence how US investors view the stock on the New York Stock Exchange under the ticker SUZ.

Over the 12?month period from April 2025 to March 2026, Suzano sold 12.7 million tonnes of pulp, the highest volume ever recorded in its history, according to a Business Wire release dated April 13, 2026. Pulp and paper sales reached 14.2 million tonnes in 2025, a 15% increase compared with 2024, underscoring continued demand for its hardwood eucalyptus pulp and fluff pulp in global markets. The company also highlighted that it is the world’s largest pulp producer, with operations centered in Brazil but customers across Asia, Europe and North America.

At the same time, Suzano and Kimberly?Clark announced the creation of a global tissue company that will operate in more than 70 countries, according to a joint Business Wire statement on April 13, 2026. The venture combines Suzano’s raw?material and pulp strengths with Kimberly?Clark’s branded tissue portfolio, including products such as Kleenex and Scott. For US investors, the deal reinforces Suzano’s role in the global tissue supply chain and may broaden its exposure to North American consumer?goods demand.

As of: 10.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Suzano S.A.
• Sector/industry: Pulp and paper
• Headquarters/country: Salvador, Brazil
• Core markets: Asia, Europe, North America
• Key revenue drivers: Hardwood eucalyptus pulp, fluff pulp, paper and tissue products
• Home exchange/listing venue: B3 (São Paulo); ADR listed on NYSE under ticker SUZ
• Trading currency: USD for ADRs on NYSE

Suzano S.A.: core business model

Suzano S.A. operates primarily through two segments: Pulp and Paper. The Pulp segment produces and sells hardwood eucalyptus pulp and fluff pulp, which are used in tissue, printing and writing paper, packaging and other applications. The company sources eucalyptus from its own plantations and third?party suppliers in Brazil, leveraging the country’s favorable climate and land base to maintain cost?competitive production.

The Paper segment focuses on producing and selling paper for both domestic and export markets, including printing and writing grades as well as specialty papers. Suzano’s integrated model—from forestry and pulp to paper and, increasingly, tissue—allows it to capture value across the supply chain and respond to shifts in global demand for fiber?based products.

For US investors, Suzano’s business is relevant because its pulp and tissue products feed into North American consumer?goods and packaging supply chains. The company’s ADR listing on the NYSE under SUZ provides direct access to its earnings and strategic moves without currency conversion at the retail level, although investors still face Brazilian macro and commodity?price risks.

Main revenue and product drivers for Suzano S.A.

Hardwood eucalyptus pulp is Suzano’s primary revenue driver, accounting for the bulk of its sales volume and value. The company’s record 12.7 million tonnes of pulp sold in the 12 months through March 2026, as reported in the April 13, 2026, Business Wire release, reflect strong demand from tissue, packaging and specialty?paper producers worldwide. Fluff pulp, used in absorbent hygiene products, is another key product line that benefits from rising global consumption of diapers, feminine care and incontinence products.

The new joint venture with Kimberly?Clark adds a tissue?focused revenue stream that could diversify Suzano’s earnings profile over time. By combining Suzano’s pulp and raw?material capabilities with Kimberly?Clark’s branded tissue portfolio, the venture aims to strengthen supply?chain resilience and capture growth in emerging?market tissue consumption. For US investors, this partnership may enhance Suzano’s visibility in the North American consumer?goods sector, even though the company remains headquartered in Brazil.

Environmental and sustainability initiatives also play into Suzano’s revenue and brand positioning. The company has connected more than 214,000 hectares of native forest in Brazil’s Atlantic Forest, Cerrado and Amazon biomes through ecological corridors, according to the same April 13, 2026, Business Wire release. These efforts support certification schemes and ESG?oriented procurement policies among global buyers, which can help secure long?term contracts and premium pricing in certain segments.

Conclusion

Suzano S.A. is emerging from a period of record pulp volumes and a strategic tissue?focused joint venture with Kimberly?Clark, both of which underscore its position as a global pulp leader. The company’s integrated forestry?to?pulp?to?tissue model offers exposure to long?term demand for fiber?based products, including tissue and packaging, while its ADR listing on the NYSE provides US investors with a direct route to that exposure.

At the same time, Suzano remains exposed to Brazilian macroeconomic conditions, commodity?price cycles and global trade dynamics, which can influence earnings volatility and stock performance. The new tissue venture with Kimberly?Clark may help diversify revenue and strengthen supply?chain relationships, but it also introduces execution and integration risks that investors will need to monitor.

For US retail investors, Suzano S.A. represents a way to gain exposure to global pulp and tissue markets through a single ADR, but it should be viewed as part of a diversified portfolio rather than a standalone bet on Brazilian or commodity?linked assets. As with any stock, investors should consider their risk tolerance, time horizon and the broader macro backdrop before making decisions.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.